Stay updated on ARO-C3 in Renal Disease Clinical Trial
Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page
- ChecktodayChange DetectedThe page now shows a revision note for v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page adds a disease term 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' and a Genetic and Rare Diseases Information Center resource, and deletes an old funding notice and revision note. These updates are informational and do not alter the study's design or displayed results.SummaryDifference0.6%

- Check43 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center operating status. Updated page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check50 days agoChange DetectedThe glossary toggle is now visible, and QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision note now shows 'Revision: v3.4.0' replacing the previous v3.3.4.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.